The Department of Health and Human Services' National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a firm-fixed-price purchase order to Protein Technologies Inc. (PTI), a manufacturer of peptide synthesis and bioanalytical technology equipment, to acquire a PurePep Chorus UV-IR peptide synthesizer for $107,107.16. The award provides for onsite installation and a startup kit. The purchase is made using simplified acquisition procedures and...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to A & A Labs LLC, doing business as Synthetic Biomolecules. The $8,482.00 contract is for the custom synthesis of 15-mer peptides. The contract is set aside for small businesses and the awardee is a minority-owned, self-certified small disadvantaged business. The place of performance is San Diego,...
The federal contract award AG7D28P150032 was issued by the Plains Area division of the U.S. Department of Health and Human Services to JPT Peptide Technologies GMBH, a foreign-owned for-profit manufacturer of custom peptides and peptide-based products. The $9,758.50 firm fixed price purchase order is for the delivery of PEPSTAR PEPTIDE MICROARRAY PEPTIDES and does not have a set-aside designation. JPT Peptide Technologies has previously received over $250,000 in federal contract awards from...
This is a $40,500 firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Polyorg, Inc., a for-profit manufacturer located in Leominster, MA. The order is for specialized chemical reagents including Fmoc-PNA monomers and Bhoc Nucleobase Acids, which are essential starting materials for NIDDK's research on thyclotides - molecules with potential diagnostic applications. The purchase order was awarded on a sole-source basis under...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bio-Synthesis, Inc. (doing business as Dnaexam) for the custom synthesis of oligonucleotides. The contract has a ceiling value of $29,580.00 and an ultimate completion date of February 28, 2010. The agency indicates a high demand and usage level for these oligonucleotides, particularly for a recombinant vaccine project against...
This is a firm-fixed-price delivery order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Bachem Americas Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract has a ceiling value of $26,400.00 and an ultimate completion date of March 31, 2027. It is for the provision of extended stability studies of parathyroid hormone-related protein (PTH-IA) to support...
This firm fixed-price purchase order was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Genscript USA Inc., a for-profit biotechnology company, for the development of murine hybridoma and V region sequencing. The contract has a potential value of $174,903.00 and a completion date of July 14, 2021. Genscript is a provider of gene synthesis, gene editing, custom protein and antibody production, and other molecular biology services, which it has...
This purchase order contract was awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Integrated DNA Technologies, Inc. for $28,510.03. Under the terms of the contract, IDT will provide custom synthesis, purification, normalization, and delivery of nine antisense oligonucleotides to the National Institute on Drug Abuse by August 15, 2023. The ASOs will support neurotoxicity studies evaluating a potential platform for predicting adverse effects of...
Genscript USA Inc. has been awarded a $24,705 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide services for creating customized monoclonal antibodies and plasmids in support of the agency's biomedical research efforts. As the prime contractor, Genscript will leverage its expertise in gene synthesis and monoclonal antibody development to deliver the requested biological products and services. This contract...
The Defense Logistics Agency awarded a $158 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562125875 protamine 10 mg/ml vials. As the prime contractor, Amerisourcebergen will deliver 25 ml vials of the pharmaceutical product from its Conshohocken, Pennsylvania facility by September 12, 2023 in support of DLA programs. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA pharmaceuticals contract vehicle to...